◆英語タイトル:ScinoPharm Taiwan Ltd (1789) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2722
◆発行会社(調査会社):
GlobalData
◆発行日:2018年8月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
ScinoPharm Taiwan Ltd (1789) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
ScinoPharm Taiwan Ltd (ScinoPharm) provides process research and development (R&D) and active pharmaceutical ingredient (API) manufacturing services to the pharmaceutical industry worldwide. It provides services such as custom synthesis for early phase pharmaceutical activities to brand companies and APIs for the generic industry. The company also provides contract research and manufacturing services (CRAM) services including chemistry skill, analytical and regulatory services, chemical process development, clinical drug substances, exploratory process research and consulting services. ScinoPharm’s wholly owned subsidiaries include SPT International, Ltd., and ScinoPharm Singapore Pte Ltd. The company has research and manufacturing facilities in Taiwan and China. ScinoPharm is headquartered in Tainan, Taiwan.
ScinoPharm Taiwan Ltd Key Recent Developments
Feb 23,2018: ScinoPharm Reports Financial Performance for 2017
Feb 15,2017: ScinoPharm Reports Financial Performance for 2016
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
ScinoPharm Taiwan Ltd – Key Facts 5
ScinoPharm Taiwan Ltd – Key Employees 6
ScinoPharm Taiwan Ltd – Key Employee Biographies 7
ScinoPharm Taiwan Ltd – Major Products and Services 8
ScinoPharm Taiwan Ltd – History 10
ScinoPharm Taiwan Ltd – Company Statement 11
ScinoPharm Taiwan Ltd – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
ScinoPharm Taiwan Ltd – Business Description 15
ScinoPharm Taiwan Ltd – Corporate Strategy 16
ScinoPharm Taiwan Ltd – SWOT Analysis 17
SWOT Analysis – Overview 17
ScinoPharm Taiwan Ltd – Strengths 17
ScinoPharm Taiwan Ltd – Weaknesses 18
ScinoPharm Taiwan Ltd – Opportunities 19
ScinoPharm Taiwan Ltd – Threats 20
ScinoPharm Taiwan Ltd – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
ScinoPharm Taiwan Ltd, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Feb 23, 2018: ScinoPharm Reports Financial Performance for 2017 32
Feb 15, 2017: ScinoPharm Reports Financial Performance for 2016 33
Section 6 – Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Tables
ScinoPharm Taiwan Ltd, Key Facts 5
ScinoPharm Taiwan Ltd, Key Employees 6
ScinoPharm Taiwan Ltd, Key Employee Biographies 7
ScinoPharm Taiwan Ltd, Major Products and Services 8
ScinoPharm Taiwan Ltd, History 10
ScinoPharm Taiwan Ltd, Other Locations 13
ScinoPharm Taiwan Ltd, Subsidiaries 13
ScinoPharm Taiwan Ltd, Key Competitors 21
ScinoPharm Taiwan Ltd, Ratios based on current share price 22
ScinoPharm Taiwan Ltd, Annual Ratios 23
ScinoPharm Taiwan Ltd, Annual Ratios (Cont...1) 24
ScinoPharm Taiwan Ltd, Annual Ratios (Cont...2) 25
ScinoPharm Taiwan Ltd, Interim Ratios 27
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
ScinoPharm Taiwan Ltd, Recent Deals Summary 31
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37
List of Figures
ScinoPharm Taiwan Ltd, Performance Chart (2013 - 2017) 26
ScinoPharm Taiwan Ltd, Ratio Charts 28
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30